vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.

INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $16.1M, roughly 1.1× Fortress Biotech, Inc.). INTERGROUP CORP runs the higher net margin — 8.8% vs -24.5%, a 33.3% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs 6.3%). Over the past eight quarters, Fortress Biotech, Inc.'s revenue compounded faster (11.0% CAGR vs 7.8%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.

FBIO vs INTG — Head-to-Head

Bigger by revenue
INTG
INTG
1.1× larger
INTG
$17.3M
$16.1M
FBIO
Growing faster (revenue YoY)
INTG
INTG
+13.5% gap
INTG
19.8%
6.3%
FBIO
Higher net margin
INTG
INTG
33.3% more per $
INTG
8.8%
-24.5%
FBIO
Faster 2-yr revenue CAGR
FBIO
FBIO
Annualised
FBIO
11.0%
7.8%
INTG

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
FBIO
FBIO
INTG
INTG
Revenue
$16.1M
$17.3M
Net Profit
$-3.9M
$1.5M
Gross Margin
66.1%
Operating Margin
-28.8%
11.6%
Net Margin
-24.5%
8.8%
Revenue YoY
6.3%
19.8%
Net Profit YoY
41.8%
155.6%
EPS (diluted)
$-0.15
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
INTG
INTG
Q4 25
$16.1M
$17.3M
Q3 25
$17.6M
$17.9M
Q2 25
$16.4M
$16.2M
Q1 25
$13.1M
$16.8M
Q4 24
$15.1M
$14.4M
Q3 24
$14.6M
$16.9M
Q2 24
$14.9M
$13.4M
Q1 24
$13.0M
$14.9M
Net Profit
FBIO
FBIO
INTG
INTG
Q4 25
$-3.9M
$1.5M
Q3 25
$5.8M
$-535.0K
Q2 25
$15.5M
$-2.2M
Q1 25
$-10.6M
$-578.0K
Q4 24
$-6.8M
$-2.7M
Q3 24
$-12.9M
$-398.0K
Q2 24
$-10.9M
$-4.9M
Q1 24
$-15.4M
$-3.2M
Gross Margin
FBIO
FBIO
INTG
INTG
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
INTG
INTG
Q4 25
-28.8%
11.6%
Q3 25
-38.6%
15.3%
Q2 25
-222.2%
8.1%
Q1 25
-169.9%
14.0%
Q4 24
-158.3%
5.9%
Q3 24
-151.0%
18.5%
Q2 24
-186.5%
3.7%
Q1 24
-280.6%
4.8%
Net Margin
FBIO
FBIO
INTG
INTG
Q4 25
-24.5%
8.8%
Q3 25
33.2%
-3.0%
Q2 25
94.4%
-13.9%
Q1 25
-80.6%
-3.4%
Q4 24
-44.7%
-18.9%
Q3 24
-88.0%
-2.4%
Q2 24
-73.5%
-36.7%
Q1 24
-118.3%
-21.3%
EPS (diluted)
FBIO
FBIO
INTG
INTG
Q4 25
$-0.15
$0.71
Q3 25
$0.11
$-0.25
Q2 25
$0.45
Q1 25
$-0.48
$-0.27
Q4 24
$-0.16
$-1.26
Q3 24
$-0.76
$-0.18
Q2 24
$-0.73
Q1 24
$-1.04
$-1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
INTG
INTG
Cash + ST InvestmentsLiquidity on hand
$79.4M
$7.5M
Total DebtLower is stronger
$52.4M
$233.2M
Stockholders' EquityBook value
$49.9M
$-85.2M
Total Assets
$185.5M
$101.1M
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
INTG
INTG
Q4 25
$79.4M
$7.5M
Q3 25
$86.2M
$6.0M
Q2 25
$74.4M
$6.1M
Q1 25
$91.3M
$4.8M
Q4 24
$57.3M
$15.4M
Q3 24
$58.9M
$12.2M
Q2 24
$76.2M
$11.6M
Q1 24
$83.8M
$19.5M
Total Debt
FBIO
FBIO
INTG
INTG
Q4 25
$52.4M
$233.2M
Q3 25
$47.8M
$237.8M
Q2 25
$50.0M
$240.5M
Q1 25
$56.4M
$241.5M
Q4 24
$58.0M
$227.2M
Q3 24
$52.5M
$218.1M
Q2 24
$67.0M
$225.7M
Q1 24
$61.4M
$225.0M
Stockholders' Equity
FBIO
FBIO
INTG
INTG
Q4 25
$49.9M
$-85.2M
Q3 25
$55.9M
$-86.7M
Q2 25
$43.9M
$-86.1M
Q1 25
$22.3M
$-84.5M
Q4 24
$22.7M
$-83.9M
Q3 24
$21.2M
$-80.9M
Q2 24
$17.9M
$-80.3M
Q1 24
$23.0M
$-76.4M
Total Assets
FBIO
FBIO
INTG
INTG
Q4 25
$185.5M
$101.1M
Q3 25
$181.4M
$102.5M
Q2 25
$159.9M
$104.1M
Q1 25
$178.1M
$103.2M
Q4 24
$144.2M
$110.6M
Q3 24
$127.1M
$109.3M
Q2 24
$145.7M
$107.8M
Q1 24
$164.6M
$119.0M
Debt / Equity
FBIO
FBIO
INTG
INTG
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
INTG
INTG
Operating Cash FlowLast quarter
$-12.5M
$-23.0K
Free Cash FlowOCF − Capex
$-481.0K
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters
$739.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
INTG
INTG
Q4 25
$-12.5M
$-23.0K
Q3 25
$-6.1M
$-296.0K
Q2 25
$-27.6M
$5.9M
Q1 25
$-19.6M
$-854.0K
Q4 24
$-12.9M
$-781.0K
Q3 24
$-20.1M
$3.4M
Q2 24
$-21.8M
$6.8M
Q1 24
$-25.4M
$1.9M
Free Cash Flow
FBIO
FBIO
INTG
INTG
Q4 25
$-481.0K
Q3 25
$-1.3M
Q2 25
$3.6M
Q1 25
$-1.2M
Q4 24
$-1.1M
Q3 24
$3.1M
Q2 24
$2.7M
Q1 24
$1.1M
FCF Margin
FBIO
FBIO
INTG
INTG
Q4 25
-2.8%
Q3 25
-7.1%
Q2 25
22.5%
Q1 25
-6.8%
Q4 24
-7.8%
Q3 24
18.3%
Q2 24
20.4%
Q1 24
7.6%
Capex Intensity
FBIO
FBIO
INTG
INTG
Q4 25
2.6%
Q3 25
5.4%
Q2 25
13.9%
Q1 25
1.8%
Q4 24
2.4%
Q3 24
0.0%
1.6%
Q2 24
30.4%
Q1 24
4.9%
Cash Conversion
FBIO
FBIO
INTG
INTG
Q4 25
-0.02×
Q3 25
-1.04×
Q2 25
-1.78×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FBIO
FBIO

Segment breakdown not available.

INTG
INTG

Hotel Operations$12.7M73%
Real Estate Operation$4.6M27%

Related Comparisons